Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production

Kidney International

Volumn 85, Issue 2, 2014, Pages 276-288

  He, Kang ^a   Chen, Xiaosong ^a   Han, Conghui ^b   Xu, Longmei ^a   Zhang, Jianjun ^a   Zhang, Ming ^a   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

HIF 2 ; ischemia reperfusion; kidney; LPS; nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; LIVER CELL; MICROCIRCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL PROTECTION; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION;

ACUTE KIDNEY INJURY; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; MICROCIRCULATION; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RENAL CIRCULATION; REPERFUSION INJURY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; WARM ISCHEMIA;

EID: 84893322248     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.342     Document Type: Article

References (74)

1. Zager RA, Johnson AC, Lund S. Endotoxin tolerance TNF-Alpha hyperreactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int 2007; 71: 496-503
2. Chatterjee PK, Zacharowski K, Cuzzocrea S et al. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury. Kidney Int 2002; 62: 1249-1263
3. Collino M, Patel NS, Lawrence KM et al. The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int 2005; 68: 529-536
4. Heemann U, Szabo A, Hamar P et al. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: Possible connection to an interleukin-6-dependent pathway. Am J Pathol 2000; 156: 287-293
5. Eckle T, Kohler D, Lehmann R et al. Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation 2008; 118: 166-175
6. Taie S, Ono J, Iwanaga Y et al. Hypoxia-inducible factor-1 alpha has a key role in hypoxic preconditioning. J Clin Neurosci 2009; 16: 1056-1060
7. Yang CC, Lin LC, Wu MS et al. Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling. Transplantation 2009; 88: 1251-1260
8. Yeh CH, Hsu SP, Yang CC et al. Hypoxic preconditioning reinforces HIF-Alpha-dependent HSP70 signaling to reduce ischemic renal failureinduced renal tubular apoptosis and autophagy. Life Sci 2010; 86: 115-123
9. Zhang S, Han CH, Chen XS et al. Transient ureteral obstruction prevents against kidney ischemia/reperfusion injury via hypoxia-inducible factor (HIF)-2alpha activation. PLoS One 2012; 7: E29876
10. Sawyer RG, Spengler MD, Adams RB et al. The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann Surg 1991; 213: 253-260
11. Blouin CC, Page EL, Soucy GM et al. Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1alpha. Blood 2004; 103: 1124-1130
12. Frede S, Stockmann C, Freitag P et al. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 2006; 396: 517-527
13. Kim HY, Kim YH, Nam BH et al. HIF-1alpha expression in response to lipopolysaccaride mediates induction of hepatic inflammatory cytokine TNFalpha. Exp Cell Res 2007; 313: 1866-1876
14. Nishi K, Oda T, Takabuchi S et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal 2008; 10: 983-995
15. Pchejetski D, Nunes J, Coughlan K et al. The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1alpha protein, activation of ASK1 and production of the proinflammatory cytokine IL-6. Immunol Cell Biol 2011; 89: 268-274
16. Peyssonnaux C, Datta V, Cramer T et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005; 115: 1806-1815
17. Peyssonnaux C, Cejudo-Martin P, Doedens A et al. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide- induced sepsis. J Immunol 2007; 178: 7516-7519
18. Imtiyaz HZ, Williams EP, Hickey MM et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 2010; 120: 2699-2714
19. Rosenberger C, Mandriota S, Jurgensen JS et al. Expression of hypoxiainducible factor-1alpha and-2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002; 13: 1721-1732
20. Shin HM, Kim MH, Kim BH et al. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett 2004; 571: 50-54
21. Mako V, Czucz J, Weiszhar Z et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1beta, TNF-Alpha, and LPS. Cytometry 2010; 77: 962-970
22. Jantsch J, Wiese M, Schodel J et al. Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1alpha (HIF1A) and result in differential HIF1A-dependent gene expression. J Leuk Biol 2011; 90: 551-562
23. Donnahoo KK, Meng X, Ayala A et al. Early kidney TNF-Alpha expression mediates neutrophil infiltration and injury after renal ischemiareperfusion. Am J Physiol 1999; 277: R922-R929
24. Kim M, Park SW, Chen SW et al. Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2010; 299: F347-F358
25. Gruber M, Hu CJ, Johnson RS et al. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci USA 2007; 104: 2301-2306
26. Maxwell PH, Osmond MK, Pugh CW et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993; 44: 1149-1162
27. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 983-989
28. Yeh CH, Chou W, Chu CC et al. Anticancer agent 2-methoxyestradiol improves survival in septic mice by reducing the production of cytokines and nitric oxide. Shock 2011; 36: 510-516
29. Lee HJ, Kim KW. Anti-inflammatory effects of arbutin in lipopolysaccharide-stimulated BV2 microglial cells. Inflamm Res 2012; 61: 817-825
30. Wang YP, Sato C, Mizoguchi K et al. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res 2002; 56: 33-42
31. Park KM, Kim JI, Ahn Y et al. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004; 279: 52282-52292
32. Park KM, Byun JY, Kramers C et al. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266
33. Ha T, Hua F, Liu X et al. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2008; 78: 546-553
34. Rosenzweig HL, Minami M, Lessov NS et al. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: A novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab 2007; 27: 1663-1674
35. Obermaier R, Drognitz O, Grub A et al. Endotoxin preconditioning in pancreatic ischemia/reperfusion injury. Pancreas 2003; 27: E51-e56
36. Godet C, Goujon JM, Petit I et al. Endotoxin tolerance enhances interleukin-10 renal expression and decreases ischemia-reperfusion renal injury in rats. Shock 2006; 25: 384-388
37. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
38. Ignarro LJ, Byrns RE, Buga GM et al. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: Use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxideelicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 1988; 244: 181-189
39. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
40. Fleming I, Busse R. NO: The primary EDRF. J Mol Cell Cardiol 1999; 31: 5-14
41. Adachi Y, Hashimoto K, Ono N et al. Renal effects of a nitric oxide donor, NOC 7, in anesthetized rabbits. Eur J Pharmacol 1997; 324: 223-226
42. Thorup C, Persson AE. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol 1994; 267: F606-F611
43. Radermacher J, Klanke B, Schurek HJ et al. Importance of NO/EDRF for glomerular and tubular function: Studies in the isolated perfused rat kidney. Kidney Int 1992; 41: 1549-1559
44. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1990; 1: 875-881
45. Kwon O, Hong SM, Ramesh G. Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion. Am J Physiol Renal Physiol 2009; 296: F25-F33
46. DeMeester SL, Qiu Y, Buchman TG et al. Nitric oxide inhibits stressinduced endothelial cell apoptosis. Crit Care Med 1998; 26: 1500-1509
47. Martinez-Mier G, Toledo-Pereyra LH, Bussell S et al. Nitric oxide diminishes apoptosis and p53 gene expression after renal ischemia and reperfusion injury. Transplantation 2000; 70: 1431-1437
48. Branco-Price C, Zhang N, Schnelle M et al. Endothelial cell HIF-1alpha and HIF-2alpha differentially regulate metastatic success. Cancer Cell 2012; 21: 52-65
49. Coulet F, Nadaud S, Agrapart M et al. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 2003; 278: 46230-46240
50. Yang S, Kim J, Ryu JH et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010; 16: 687-693
51. Kim JI, Jang HS, Park KM. Endotoxin-induced renal tolerance against ischemia and reperfusion injury is removed by iNOS, but not eNOS, genedeletion. BMB Rep 2010; 43: 629-634
52. Li L, Okusa MD. Macrophages, dendritic cells, and kidney ischemiareperfusion injury. Semin Nephrol 2010; 30: 268-277
53. Ates E, Genc E, Erkasap N et al. Renal protection by brief liver ischemia in rats. Transplantation 2002; 74: 1247-1251
54. Cho WY, Choi HM, Lee SY et al. The role of Tregs and CD11c() macrophages/dendritic cells in ischemic preconditioning of the kidney. Kidney Int 2010; 78: 981-992
55. Zhang MZ, Yao B, Yang S et al. CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest 2012; 122: 4519-4532
56. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82
57. Wiesener MS, Jurgensen JS, Rosenberger C et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-273
58. Leek RD, Talks KL, Pezzella F et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res 2002; 62: 1326-1329
59. Ramadori P, Ahmad G, Ramadori G. Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: A role for IL-6. Lab Invest 2010; 90: 1306-1324
60. Schneider A, Zhang Y, Guan Y et al. Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am J Physiol Renal Physiol 2003; 284: F411-F417
61. Alonzi T, Maritano D, Gorgoni B et al. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 2001; 21: 1621-1632
62. Duan LJ, Zhang-Benoit Y, Fong GH. Endothelium-intrinsic requirement for Hif-2alpha during vascular development. Circulation 2005; 111: 2227-2232
63. Kisanuki YY, Hammer RE, Miyazaki J et al. Tie2-Cre transgenic mice: A new model for endothelial cell-lineage analysis in vivo. Dev Biol 2001; 230: 230-242
64. Skuli N, Liu L, Runge A et al. Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 2009; 114: 469-477
65. Tang N, Mack F, Haase VH et al. pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 2006; 26: 2519-2530
66. Yim SH, Shah Y, Tomita S et al. Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice. Hepatology 2006; 44: 550-560
67. Hu G, Xue J, Duan H et al. IFN-gamma induces IFN-Alpha and IFN-beta expressions in cultured rat intestinal mucosa microvascular endothelial cells. Immunopharmacol Immunotoxicol 2010; 32: 656-662
68. Hayashi M, Kim SW, Imanaka-Yoshida K et al. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest 2004; 113: 1138-1148
69. Kojima I, Tanaka T, Inagi R et al. Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney. J Am Soc Nephrol 2007; 18: 1218-1226
70. Serpe MJ, Zhang X. The principles, development and application of microelectrodes for the in vivo determination of nitric oxide In: Michael AC, Borland LM (eds). (Electrochemical Methods for Neuroscience: Boca Raton, FL, USA, 2007
71. Perkins KA, Pershad S, Chen Q et al. The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R). Naunyn Schmiedebergs Arch Pharmacol 2012; 385: 27-38
72. Chen Q, Kim EE, Elio K et al. The role of tetrahydrobiopterin and dihydrobiopterin in ischemia/reperfusion injury when given at reperfusion. Adv Pharmacol Sci 2010; 2010: 963914
73. Guo JY, Yang T, Sun XG et al. Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway. J Biomed Sci 2011; 18: 79
74. Habibey R, Ajami M, Ebrahimi SA et al. Nitric oxide and renal protection in morphine-dependent rats. Free Radic Biol Med 2010; 49: 1109-1118